Executive Incentives Combining Cash and Equity Compensation
First written in FY2021. 13 of 14 entries say "Advanced", first in FY2022-Q1. Latest entry: FY2026.
- FY2026AdvancedAnnual report
「Summary of issuance during the fiscal year (resolution of the Board of Directors dated 28 April 2025): New shares issued: 700 / Treasury shares disposed of: 18,800」
We allotted 700 new shares and 18,800 treasury shares as restricted stock compensation for directors, continuing and implementing the scheme combining cash and share-based compensation. - 2026-06-03AdvancedGeneral Meetings of Shareholders
「各取締役（監査等委員である取締役を除く）の報酬額は、短期インセンティブの付与を目的とした金銭報酬及び中長期インセンティブ付与を目的とした株式報酬の混合で構成」
金銭報酬と株式報酬を組み合わせる報酬方針を明文化し、当事業年度に取締役1名へ19,500株を交付した。 - FY2026-H1AdvancedAnnual report
「Increase through the issuance of new shares as restricted stock compensation / Series 21 Stock Acquisition Rights / 1 company employee / Common shares, 8,300」
We continued issuing restricted stock compensation and additionally granted 8,300 stock acquisition rights to 1 employee. - FY2025-H1AdvancedAnnual report
「Increase through the issuance of new shares as restricted stock compensation / Issue price: ¥1,875 / Amount included in capital: ¥938 / Principal allottees: 3 directors of our company」
On 15 May 2024, we issued 27,500 restricted shares to 3 directors as share-based compensation, continuing and expanding the executive incentive scheme combining cash and share-based compensation. - FY2024AdvancedAnnual report
「Summary of issuance during the fiscal year (resolution of the Board of Directors dated 28 April 2023): Number of shares issued: 21,900 / Issue price: ¥2,352 per share」
We issued 21,900 restricted shares to directors and continued and implemented the incentive scheme combining cash and share-based compensation. - FY2024-Q2AdvancedAnnual report
「Series 16 Stock Acquisition Rights / Category and number of eligible recipients: 6 employees of our company; 1 director of a subsidiary / Number of stock acquisition rights: 402 / Class, description and number of shares underlying the stock acquisition rights: Common shares, 40,200」
We provided additional share-based compensation for officers and employees by establishing stock acquisition rights for employees and directors of subsidiaries. - FY2024-Q1AdvancedAnnual report
「19 May 2023 / Increase through a gratuitous third-party allotment as restricted stock compensation / Principal allottees: 3 directors of our company」
On 19 May 2023, we issued 21,900 restricted shares to 3 directors as additional share-based compensation. - FY2023AdvancedAnnual report
「Summary of issuance during the fiscal year (resolution of the Board of Directors dated 28 April 2022): Number of shares issued: 18,500」
We issued 18,500 restricted shares to 3 directors as share-based compensation, resulting in share-based compensation expense of ¥178 million. In addition, after filing, we disclosed the planned issuance of 21,900 restricted shares to 3 directors. - FY2023-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 31 October 2022, we resolved to allot stock acquisition rights as stock options to our employees.」
We resolved to allot Series 14 Stock Acquisition Rights representing 34,500 shares to 10 employees, expanding the scope of share-based compensation. - FY2022AdvancedAnnual report
「Series 13 Stock Acquisition Rights / Resolution date: 28 April 2022 / Category and number of eligible recipients: Employees of our company, 45」
We granted stock acquisition rights representing 108,000 shares to 45 employees and expanded share-based compensation by issuing 18,500 restricted shares to 2 directors and 1 employee. - FY2022-Q3AdvancedAnnual report
「Series 12 Stock Acquisition Rights / Resolution date: 13 December 2021 / Category and number of eligible recipients: External collaborator of our company, 1 / Number of stock acquisition rights: 23 / Class, description and number of shares underlying the stock acquisition rights: Common shares, 2,300」
In addition to employees, we resolved to issue Series 12 Stock Acquisition Rights to 1 external collaborator, comprising 23 rights and 2,300 underlying shares. - FY2022-Q2AdvancedAnnual report
「At a meeting of the Board of Directors held on 1 November 2021, we resolved to issue stock acquisition rights as stock options for our employees, with 17 November 2021 as the allotment date.」
We resolved to issue 251 Series 11 Stock Acquisition Rights, representing 25,100 underlying shares, to 6 employees. - FY2022-Q1AdvancedAnnual report
「New shares were issued as specified restricted stock. Issue price: ¥4,555 per share. Amount included in capital: ¥2,277.5 per share. Allottees: 2 directors and 1 employee of our company」
As part of share-based compensation for directors and employees, we issued 13,900 shares of specified restricted stock. - FY2021First statedAnnual report
「The compensation of each director, excluding directors who are Audit and Supervisory Committee members, comprises a combination of cash compensation intended to provide short-term incentives and share-based compensation intended to provide medium- to long-term incentives. Decisions on the ratios and breakdown are considered from multiple perspectives, taking appropriate account of the internal and external environment surrounding our company, including the LITALICO Group's overall business performance, profit and growth rates, budgeting policies, and market trends, including market value, as well as business performance and other factors.」
A compensation policy combining short-term cash compensation with medium- to long-term restricted stock and stock acquisition rights.